Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-services domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-payments domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121
Toxoplasma gondii – benchmark antibodies Toxoplasma gondii
Skip to content

Showing 1–10 of 12 results



Toxoplasma gondii:
Toxoplasma gondii is a protozoan parasite belonging to the Apicomplexa phylum. It is an obligate intracellular parasite with a complex life cycle involving both intermediate hosts, such as mammals and birds, and definitive hosts, typically felids (cats). T. gondii is known for causing toxoplasmosis, a disease that can affect various organs and tissues.

Diseases caused by Toxoplasma gondii:
Toxoplasmosis can manifest as a mild flu-like illness in healthy individuals, but it poses a significant risk to immunocompromised individuals and pregnant women. In pregnant women, the parasite can cross the placenta, leading to congenital toxoplasmosis, which can result in severe neurological and ocular abnormalities in the developing fetus. Immunocompromised individuals, such as those with HIV/AIDS or undergoing organ transplantation, are susceptible to severe and potentially fatal toxoplasmosis.

Detection and Diagnosis of Toxoplasma gondii:
Diagnosing toxoplasmosis involves laboratory tests to detect T. gondii-specific antibodies. Enzyme-linked immunosorbent assays (ELISA), like the assays provided here, are commonly used for serological testing, measuring the levels of IgG and IgM antibodies against T. gondii. Molecular methods, such as polymerase chain reaction (PCR), can be employed to detect the parasite’s DNA in clinical samples. Prenatal screening for pregnant women and monitoring immunocompromised individuals are crucial for early detection and management of toxoplasmosis. Prevention strategies include proper hygiene, especially avoiding undercooked meat and contact with cat feces, and antiparasitic medications for those at high risk.